Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer.
Saout K, Zambon A, Nguyen TA, Lucas C, Payrard-Starck C, Segalen T, Tissot V, Doucet L, Marolleau J, Deruelle C, Joulin V, Fourcade A, Fournier G, Valeri A. Saout K, et al. Among authors: doucet l. Clin Genitourin Cancer. 2022 Jun;20(3):e244-e252. doi: 10.1016/j.clgc.2022.01.015. Epub 2022 Jan 31. Clin Genitourin Cancer. 2022. PMID: 35216924
The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer.
Fourcade A, Payrard C, Tissot V, Perrouin-Verbe MA, Demany N, Serey-Effeil S, Callerot P, Coquet JB, Doucet L, Deruelle C, Joulin V, Nonent M, Fournier G, Valeri A. Fourcade A, et al. Among authors: doucet l. Scand J Urol. 2018 Jun;52(3):174-179. doi: 10.1080/21681805.2018.1438509. Epub 2018 Feb 20. Scand J Urol. 2018. PMID: 29463177
Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C, Fourcade A, An Nguyen T, Tissot V, Doucet L, Marolleau J, Lucas C, Fournier G, Valeri A. Payrard-Starck C, et al. Among authors: doucet l. Prog Urol. 2023 Apr;33(5):265-271. doi: 10.1016/j.purol.2023.01.004. Epub 2023 Feb 4. Prog Urol. 2023. PMID: 36740508 Clinical Trial.
Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S, Mathieu R, Leger J, Haillot O, Vincendeau S, Rioux-Leclercq N, Fournier G, Perrouin-Verbe MA, Doucet L, Azzouzi AR, Rigaud J, Renaudin K, Charles T, Bruyere F, Fromont G. Lebdai S, et al. Among authors: doucet l. Urol Oncol. 2018 Feb;36(2):80.e17-80.e24. doi: 10.1016/j.urolonc.2017.09.026. Epub 2017 Nov 16. Urol Oncol. 2018. PMID: 29153942
External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer.
Bourbonne V, Fournier G, Vallières M, Lucia F, Doucet L, Tissot V, Cuvelier G, Hue S, Le Penn Du H, Perdriel L, Bertrand N, Staroz F, Visvikis D, Pradier O, Hatt M, Schick U. Bourbonne V, et al. Among authors: doucet l. Cancers (Basel). 2020 Mar 28;12(4):814. doi: 10.3390/cancers12040814. Cancers (Basel). 2020. PMID: 32231077 Free PMC article.
128 results